Rheumatic Immune-Related Adverse Events: Immune Checkpoint Inhibitor Therapy and Ramifications for Health Disparities
{{output}}
Introduction: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy; however, they have been associated with clinically significant immune-related adverse events (irAEs), including rheumatic irAEs. Rheumatic irAE... ...
